Shuttle Pharmaceuticals Holdings (SHPH) Operating Income (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Operating Income history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• In Q1 2026, Operating Income rose 24.89% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 20.73% YoY), while the FY2025 annual figure was -$11.9 million, down 54.84% from the prior year.
• Operating Income was -$2.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$2.8 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$353626.0 in Q2 2022 to a low of -$3.9 million in Q2 2025.
• Historically, Operating Income has averaged -$1.8 million across 5 years, with a median of -$1.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Income plunged 314.46% in 2023, then climbed 25.71% in 2025.
• A 5-year view of Operating Income shows it stood at -$530336.0 in 2022, then tumbled by 141.89% to -$1.3 million in 2023, then sank by 38.53% to -$1.8 million in 2024, then tumbled by 56.9% to -$2.8 million in 2025, then grew by 20.49% to -$2.2 million in 2026.
• The last three Operating Income figures came in at -$2.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.